1-14 of 14
Natalie Schub
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of Teclistamab-Based Induction Regimens in Patients with Transplant-Eligible (TE) Newly Diagnosed Multiple Myeloma (NDMM): Results from the GMMG-HD10/DSMM-XX (MajesTEC-5) Trial

Marc S. Raab, Niels Weinhold, K. Martin Kortüm, Jan Krönke, Lilli Podola, Uta Bertsch, Jan H. Frenking, Julia Mersi, Stefanie Huhn, Michael Hundemer, Gunhild Mechtersheimer, Roland Fenk, Katja C. Weisel, Natalie Schub, Florian Bassermann, Monika Engelhardt, Raphael Teipel, Mathias Hänel, Hans Salwender, Bas D Koster, Elena Ershova, Caline Sakabedoyan, Isobel Barrott, Agnes Balogh, Sanjay Vara, Tobias Kampfenkel, Hartmut Goldschmidt, Hermann Einsele, Leo Rasche
Journal: Blood
Blood (2024) 144 (Supplement 1): 493.
https://doi.org/10.1182/blood-2024-206003
Published: 2024
Journal Articles

Idecabtagene Vicleucel (ide-cel) Shows Similar Efficacy and Toxicity in Patients with Multiple Myeloma Aged 70 and Older Compared to Younger Patients: A Multicenter Cohort Study

Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, Anca Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Christian R Schultze-Florey, Simon Call, Natalie Schub, Annamaria Brioli, Michael Daskalakis, Juliane Knust, Justin Hasenkamp, Matthias Stelljes, Cyrus Khandanpour, Ulrike Bacher, Christine Hanoun, Florian Heidel, Hans Christian Reinhardt, Georg Lenz, Gerald Wulf, Friedrich Stölzel, Bastian von Tresckow, Thomas Pabst, Evgenii Shumilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 3383.
https://doi.org/10.1182/blood-2024-198763
Published: 2024
Journal Articles

Cilta-Cel Is Associated with Improved Outcomes and Distinct Cellular Dynamics Compared with Ide-Cel for Relapsed or Refractory Multiple Myeloma

Nico Gagelmann, Friedrich Stölzel, Roland Fenk, Tobias A.W. Holderried, Fabian Mueller, Natalia Tovar, Aina Oliver-Caldés, Kristin Rathje, Vladan Vucinic, Soraya Kharboutli, Ben-Niklas Bärmann, Francis A. Ayuk, Uwe Platzbecker, Anca Maria Albici, Natalie Schub, Friederike Schmitz, Cyrus Khandanpour, Marcel Teichert, Barbara Jeker, Nicolaus Kroeger, Bastian von Tresckow, Carlos Fernandez de Larrea, Thomas Pabst, Maximilian Merz
Journal: Blood
Blood (2024) 144 (Supplement 1): 2003.
https://doi.org/10.1182/blood-2024-211410
Published: 2024
Journal Articles

Efficacy of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed/Refractory Multiple Myeloma and Prior Central Nervous System Manifestation: A Retrospective Real-World Analysis

Markus Maulhardt, Philipp Berning, Christine Hanoun, Hristo Boyadzhiev, Anca Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Simon Call, Natalie Schub, Enver Aydilek, Michael Daskalakis, Wolfram Jung, Justin Hasenkamp, Carolin Krekeler, Cyrus Khandanpour, Ulrike Bacher, Hans Christian Reinhardt, Georg Lenz, Friedrich Stölzel, Gerald Wulf, Thomas Pabst, Bastian von Tresckow, Evgenii Shumilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 4759.
https://doi.org/10.1182/blood-2024-202467
Published: 2024
Journal Articles

Circulating Tumor DNA Kinetics at Day 14 after CAR T-Cell Therapy Identifies Patients with B-Cell Lymphoma at Risk for Early Treatment Failure

Tim Versteegen, Philipp Nakov, Nikos Darzentas, Guranda Chitadze, Ingram Iaccarino, Wolfram Klapper, Natalie Schub, Monika Brüggemann, Friedrich Stoelzel, Claudia D Baldus, Christiane Pott, Mouhamad Khouja
Journal: Blood
Blood (2024) 144 (Supplement 1): 2959.
https://doi.org/10.1182/blood-2024-207721
Published: 2024
Journal Articles

Pseudoprogression As Adverse Event of Chimeric Antigen Receptor T Cell Therapy

Torsten Schroeder, Tjark Martens, Guranda Chitadze, Fatih Yalcin, Heiko Trautmann, Monika Brüggemann, Christine Heinen, Philipp Nakov, Anca Maria Albici, Nicolas Spath, Lukas Sprenger, Laura Jane Kramp, Matthias Ritgen, Dominique Wellnitz, Maciej Simon, Sebastian Lippross, Ingram Iaccarino, Wolfram Klapper, Lars Fransecky, Thomas Valerius, Natalie Schub, Christiane Pott, Claudia D Baldus, Friedrich Stoelzel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6935.
https://doi.org/10.1182/blood-2023-189047
Published: 2023
Journal Articles

Tafasitamab and Lenalidomide in Relapsed/Refractory B-Cell Lymphoma: A Multicenter Retrospective Real-World-Study of Patients from Germany and Austria

Anna Ruckdeschel, Koemm Sabrina, Max S. Topp, Richard Greil, Thomas Melchardt, Georg Lenz, Andrea Kerkhoff, Evgenii Shumilov, Georg Hess, Marta Baumgaertner, Lorenz Thurner, Igor Age Kos, Stephanie Mayer, Francis A. Ayuk, Rolf Krause, Marco Herling, Vladan Vucinic, Claudia Chapuy, Gerald Illerhaus, Markus Knott, Andreas Viardot, Alexander Grunenberg, Sascha Dietrich, Leandra Caille, Mareike C. Tometten, Hyunyee Rosa Cho, Julia Scholz, Fabian Mueller, Katharina Prochazka, Bjoern Chapuy, David Böckle, Bastian von Tresckow, Natalie Schub, Götz Gelbrich, Hermann Einsele, Johannes Duell
Journal: Blood
Blood (2023) 142 (Supplement 1): 1771.
https://doi.org/10.1182/blood-2023-185992
Published: 2023
Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

Mitja Nabergoj, Katya Mauff, Dietrich W. Beelen, MD, Arnold Ganser, Nicolaus Kröger, MD, Martin Bornhäuser, MD, Jürgen Finke, Sr., MD PhD, Jakob R. Passweg, MDMS, Jan J. Cornelissen, MD PhD, Natalie Schub, MD, Hendrik Veelken, MD PhD, Yves Beguin, MD PhD, Keith Wilson, FRCPath, MRCP, MBBS, Tsila Zuckerman, MD, Aurelien Giltat, MD, Celestine Simand, MD, Rocio Parody, MD, Pascal Turlure, MD, Tessa Kerre, MD, Linda Koster, Patrick J Hayden, MD, Francesco Onida, MD, Christof Scheid, MD, Yves Chalandon, MD, Marie Robin, MD PhD, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-137773
Published: 2020
Journal Articles

Thiotepa-Fludarabine-Treosulfan (TFT) Conditioning for 2nd Allogeneic Peripheral Blood Hematopoietic Cell Transplantation (HCT) from a Second Unrelated Donor in Patients with Acute Myeloid Leukemia (AML) Relapsed after Prior Allogeneic HCT: A Prospective Multicenter Phase II Trial

Jürgen Finke, MD, Claudia Schmoor, Matthias Stelljes, MD, Andreas Burchert, MD, Peter Dreger, Eva-Maria Wagner, MD, Martin Bornhäuser, Kristina Sohlbach, MD, Natalie Schub, MD, Christian Reicherts, Guido Kobbe, Bertram Glass, Hartmut Bertz, MD, Olga Grishina
Journal: Blood
Blood (2018) 132 (Supplement 1): 210.
https://doi.org/10.1182/blood-2018-99-118999
Published: 2018
Journal Articles

Preclinical Characterization of AFM26, a Novel B Cell Maturation Antigen (BCMA)-Directed Tetravalent Bispecific Antibody for High Affinity Retargeting of NK Cells Against Myeloma

Thorsten Ross, PhD, Uwe Reusch, PhD, Susanne Wingert, PhD, Torsten Haneke, PhD, Katja Klausz, PhD, Anna-Kathrin Otte, PhD, Natalie Schub, MD, Stefan Knackmuss, PhD, Thomas Müller, Kristina Ellwanger, PhD, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch, PhD, Thomas Valerius, MD, Martin Gramatzki, MD, Matthias Peipp, PhD, Michael Tesar, PhD, Erich Rajkovic, PhD MBA, Martin Treder, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1927.
https://doi.org/10.1182/blood-2018-99-118970
Published: 2018
Journal Articles

Immune Reconstitution after Allogeneic Stem Cell Transplantation - a Systematic Single Center Survey

Anna Sophie Hartjen, Andreas Krumbholz, MD, Florian Thieme, PhD, Natalie Schub, MD, Andreas Humpe, MD, Michaela Kotrova, Monika Brüggemann, MD, Martin Gramatzki, MD, Andreas Guenther, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5490.
https://doi.org/10.1182/blood.V130.Suppl_1.5490.5490
Published: 2017
Journal Articles

Carfilzomib in Combination with Bendamustine and Dexamethasone (CBd) in Relapsed and/or Refractory Patients with Multiple Myeloma: The Phase I/II EMN09 Study

Martin Gramatzki, Andreas Günther, Massimo Offidani, MD, Monika Engelhardt, Paolo Corradini, Silvia Gentili, Vittorio Montefusco, Francesca Patriarca, MD, Natalie Schub, Hermann Einsele, MD, Pieter Sonneveld, Antonio Palumbo, MD, Francesca Gay
Journal: Blood
Blood (2016) 128 (22): 3334.
https://doi.org/10.1182/blood.V128.22.3334.3334
Published: 2016
Journal Articles

Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation

Matthias Staudinger, PhD, Christian Kellner, PhD, Matthias Peipp, PhD, Natalie Schub, MD, Andreas Humpe, MD, Martin Gramatzki, MD
Journal: Blood
Blood (2013) 122 (21): 3972.
https://doi.org/10.1182/blood.V122.21.3972.3972
Published: 2013
Journal Articles

PBSCT Similar to BMT Allows Active B-Lymphopoiesis Unless Severe GVHD Occurs.

Julia Winkler, MD, Armin Biller, MD, Natalie Schub, MD, Wolf Rösler, MD, Kerstin Eckart-Schäfer, MD, Hannes Wandt, MD, Claudia N. Kluender, MD, Rainer Schwerdtfeger, MD, Joachim Hahn, MD, Ernst Holler, MD, Thomas H. Winkler, PD, Martin Gramatzki, MD
Journal: Blood
Blood (2005) 106 (11): 5351.
https://doi.org/10.1182/blood.V106.11.5351.5351
Published: 2005